Literature DB >> 10566626

Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers.

F Abbasi1, T McLaughlin, C Lamendola, H Yeni-Komshian, A Tanaka, T Wang, K Nakajima, G M Reaven.   

Abstract

This study was initiated to test the hypothesis that plasma concentrations of remnant lipoproteins would be higher after an overnight fast in insulin-resistant compared to insulin-sensitive volunteers. Forty-three healthy nonobese women were studied, divided into insulin-resistant (n = 21) and insulin-sensitive (n = 22) groups on the basis of their steady state plasma glucose (SSPG) concentration at the end of a 180-min infusion of octreotide acetate, insulin, and glucose. Under these conditions, steady state plasma insulin concentrations are similar in all subjects (approximately 60 microU/mL), and the higher the SSPG concentrations, the more insulin resistant the individual. By selection, mean (+/-SEM) SSPG concentrations were significantly higher (P < 0.001) in the insulin-resistant group (210 +/- 7 vs. 78 +/- 3 mg/dL). In addition, the insulin-resistant group had higher triglycerides (198 +/- 27 vs. 101 +/- 12 mg/dL; P < 0.005) and lower high density lipoprotein cholesterol (48 +/- 4 vs. 60 +/- 4 mg/dL; P < 0.05) concentrations. Finally, insulin resistance was associated with higher remnant lipoprotein particle concentrations of cholesterol (7.2 +/- 0.8 vs. 4.4 +/- 0.3; P < 0.005) and triglycerides (22.2 +/- 3.4 vs. 8.5 +/- 1.0; P < 0.001). All of these differences were seen despite the fact that the two groups were similar in terms of age and body mass index. These results identify additional abnormalities in lipoprotein metabolism that may contribute to the increased risk of coronary heart disease seen in insulin-resistant, nondiabetic subjects (syndrome X).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566626     DOI: 10.1210/jcem.84.11.6136

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.

Authors:  Pablo Pérez-Martínez; Francisco Pérez-Jiménez; José María Ordovás; Juan Antonio Moreno; Carmen Marín; Rafael Moreno; Yolanda Jiménez-Gómez; Juan Antonio Paniagua; José López-Miranda
Journal:  Lipids       Date:  2007-02-10       Impact factor: 1.880

2.  Association of BMI and fasting insulin with cardiovascular disease risk factors in seven-year-old Icelandic children.

Authors:  Hannes Hrafnkelsson; Kristjan T H Magnusson; Emil L Sigurdsson; Erlingur Johannsson
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

3.  Genome-wide association study identifies novel risk variants from RPS6KA1, CADPS, VARS, and DHX58 for fasting plasma glucose in Arab population.

Authors:  Prashantha Hebbar; Mohamed Abu-Farha; Fadi Alkayal; Rasheeba Nizam; Naser Elkum; Motasem Melhem; Sumi Elsa John; Arshad Channanath; Jehad Abubaker; Abdullah Bennakhi; Ebaa Al-Ozairi; Jaakko Tuomilehto; Janne Pitkaniemi; Osama Alsmadi; Fahd Al-Mulla; Thangavel Alphonse Thanaraj
Journal:  Sci Rep       Date:  2020-01-13       Impact factor: 4.379

4.  Association of triglyceride-glucose index and stroke recurrence among nondiabetic patients with acute ischemic stroke.

Authors:  Xiaomeng Yang; Guangyao Wang; Jing Jing; Anxin Wang; Xiaoli Zhang; Qian Jia; Xia Meng; Xingquan Zhao; Liping Liu; Hao Li; Yongjun Wang; Yilong Wang
Journal:  BMC Neurol       Date:  2022-03-08       Impact factor: 2.474

5.  Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance.

Authors:  Sachiko Hattori
Journal:  J Diabetes Investig       Date:  2017-12-27       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.